Egyptian scientists have discovered a new chemical compound that could potentially be used in therapeutic drugs. The compound, named Nyoum October 6, was developed by researchers at the National Research Centre (NRC) in Cairo.

According to the team behind the work, the compound has shown promise in the treatment of Alzheimer's and Parkinson's diseases, as well as other neurodegenerative disorders. "Nyoum October 6 has a low toxicity profile and it possesses excellent potential for use in pharmacotherapy," said Mohamed Abd El-Salam, the lead author of the study published in the Journal of Biomolecular Structure and Dynamics.

The researchers began working on the compound after observing its potential in a series of experiments using computational chemistry. They conducted additional tests in the lab to confirm its properties, and found that it was able to significantly reduce the damage caused by oxidative stress in cells.

Oxidative stress is a common factor in the development of many neurological disorders, including Alzheimer's and Parkinson's. The compound seemed to inhibit the production of reactive oxygen species that can cause cellular damage, which is one way it could be used in treatment.

There is still much work to be done before Nyoum October 6 can be put into use as a therapeutic drug, including more rigorous testing and clinical trials. But the potential of this new compound is exciting news for the field of pharmacology and for the millions of people worldwide affected by neurodegenerative diseases. So, this discovery is definitely a big step towards the development of new effective drugs for these diseases.